Pfizer Inc. (PFE) DCF Valuation

Pfizer Inc. (PFE) DCF Valuation

US | Healthcare | Drug Manufacturers - General | NYSE
Pfizer Inc. (PFE) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Pfizer Inc. (PFE) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Simplify Pfizer Inc. (PFE) valuation with this customizable DCF Calculator! Featuring real Pfizer Inc. (PFE) financials and adjustable forecast inputs, you can test scenarios and uncover Pfizer Inc. (PFE) fair value in minutes.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 51,750.0 41,908.0 81,288.0 100,330.0 58,496.0 66,784.6 76,247.7 87,051.7 99,386.6 113,469.3
Revenue Growth, % 0 -19.02 93.97 23.43 -41.7 14.17 14.17 14.17 14.17 14.17
EBITDA 18,853.0 13,168.0 30,793.0 41,031.0 9,557.0 21,767.4 24,851.8 28,373.2 32,393.6 36,983.6
EBITDA, % 36.43 31.42 37.88 40.9 16.34 32.59 32.59 32.59 32.59 32.59
Depreciation 5,795.0 4,681.0 5,191.0 5,064.0 6,290.0 5,951.0 6,794.3 7,757.0 8,856.1 10,111.0
Depreciation, % 11.2 11.17 6.39 5.05 10.75 8.91 8.91 8.91 8.91 8.91
EBIT 13,058.0 8,487.0 25,602.0 35,967.0 3,267.0 15,816.4 18,057.5 20,616.2 23,537.4 26,872.6
EBIT, % 25.23 20.25 31.5 35.85 5.58 23.68 23.68 23.68 23.68 23.68
Total Cash 9,830.0 12,221.0 31,069.0 22,732.0 12,690.0 17,461.3 19,935.5 22,760.3 25,985.3 29,667.4
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 6,772.0 7,913.0 11,479.0 10,952.0 11,177.0
Account Receivables, % 13.09 18.88 14.12 10.92 19.11
Inventories 8,283.0 8,046.0 9,059.0 8,981.0 10,189.0 9,713.0 11,089.3 12,660.6 14,454.6 16,502.8
Inventories, % 16.01 19.2 11.14 8.95 17.42 14.54 14.54 14.54 14.54 14.54
Accounts Payable 3,887.0 4,283.0 5,578.0 6,809.0 6,710.0 5,723.5 6,534.5 7,460.4 8,517.6 9,724.5
Accounts Payable, % 7.51 10.22 6.86 6.79 11.47 8.57 8.57 8.57 8.57 8.57
Capital Expenditure -2,594.0 -2,791.0 -2,711.0 -3,236.0 -3,907.0 -3,327.5 -3,799.0 -4,337.2 -4,951.8 -5,653.5
Capital Expenditure, % -5.01 -6.66 -3.34 -3.23 -6.68 -4.98 -4.98 -4.98 -4.98 -4.98
Tax Rate, % -100.28 -100.28 -100.28 -100.28 -100.28 -100.28 -100.28 -100.28 -100.28 -100.28
EBITAT 12,017.5 7,947.0 23,146.2 32,490.3 6,543.3 14,753.9 16,844.4 19,231.2 21,956.2 25,067.3
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF 4,050.5 9,329.0 22,342.2 36,154.3 7,394.3 17,877.6 17,833.9 20,360.9 23,246.0 26,539.8
WACC, % 6.32 6.34 6.29 6.29 6.43 6.33 6.33 6.33 6.33 6.33
PV UFCF
SUM PV UFCF 87,223.4
Long Term Growth Rate, % 0.50
Free cash flow (T + 1) 26,673
Terminal Value 457,128
Present Terminal Value 336,249
Enterprise Value 423,472
Net Debt 67,992
Equity Value 355,480
Diluted Shares Outstanding, MM 5,709
Equity Value Per Share 62.27

What You Will Get

  • Real PFE Financial Data: Pre-filled with Pfizer’s historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See Pfizer’s intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • Pre-Loaded Data: Pfizer Inc.'s historical financial statements and pre-filled forecasts.
  • Fully Adjustable Inputs: Modify WACC, tax rates, revenue growth, and EBITDA margins.
  • Instant Results: View Pfizer's intrinsic value recalculating in real time.
  • Clear Visual Outputs: Dashboard charts illustrate valuation results and key metrics.
  • Built for Accuracy: A professional tool designed for analysts, investors, and finance experts.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered Pfizer data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for Pfizer’s intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose This Calculator?

  • User-Friendly Interface: Perfect for both novices and seasoned professionals.
  • Customizable Inputs: Adjust parameters to suit your specific analysis needs.
  • Real-Time Feedback: Observe immediate changes to Pfizer’s valuation as you tweak inputs.
  • Preloaded Data: Comes with Pfizer’s actual financial information for swift evaluations.
  • Relied Upon by Experts: Utilized by investors and analysts for making well-informed choices.

Who Should Use This Product?

  • Pharmaceutical Students: Understand drug development processes and apply them using real-world case studies.
  • Researchers: Integrate industry-standard models into your studies or publications.
  • Healthcare Investors: Evaluate your investment strategies and analyze valuation metrics for Pfizer Inc. (PFE).
  • Market Analysts: Enhance your analysis with a customizable financial model tailored for the pharmaceutical sector.
  • Healthcare Professionals: Acquire knowledge on how major pharmaceutical companies like Pfizer are evaluated.

What the Template Contains

  • Pre-Filled Data: Contains Pfizer Inc.’s (PFE) historical financials and projections.
  • Discounted Cash Flow Model: Editable DCF valuation model featuring automatic calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC using custom inputs.
  • Key Financial Ratios: Evaluate Pfizer Inc.’s (PFE) profitability, efficiency, and leverage.
  • Customizable Inputs: Easily adjust revenue growth, margins, and tax rates.
  • Clear Dashboard: Visual representations and tables summarizing key valuation outcomes.

Es wurden keine passenden Produkte gefunden.